Daily sodium intake in chronic kidney disease patients during nephrology clinic follow-up: An observational study with 24-hour urine sodium measurement

Nephron - Clinical Practice

Volumn 118, Issue 4, 2011, Pages

  Aybal Kutlugün, Aysun ^a   Arici, Mustafa ^a   Yildirim, Tolga ^a   Turgut, Didem ^a   Yilmaz, Rahmi ^a   Altindal, Mahmut ^a   Altun, Bülent ^a   Erdem, Yunus ^a   Yasavul, Ünal ^a   Turgan, Çetin ^a  

^a HACETTEPE UNIVERSITY   (Turkey)

Author keywords

Chronic renal failure; Salt; Urinary sodium excretion

Indexed keywords

ANTIHYPERTENSIVE AGENT; THIAZIDE DIURETIC AGENT;

ADULT; AGED; ARTICLE; CHRONIC KIDNEY DISEASE; DIASTOLIC BLOOD PRESSURE; DISEASE SEVERITY; DRUG UTILIZATION; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; OBSERVATIONAL STUDY; PATIENT COMPLIANCE; PRIORITY JOURNAL; SODIUM EXCRETION; SODIUM INTAKE; SODIUM RESTRICTION; SODIUM URINE LEVEL; SYSTOLIC BLOOD PRESSURE;

ADULT; AGED; AMBULATORY CARE FACILITIES; BIOLOGICAL MARKERS; FEMALE; FOLLOW-UP STUDIES; HUMANS; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; NEPHROLOGY; RISK FACTORS; SODIUM; SODIUM, DIETARY;

EID: 79851512627     PISSN: None     EISSN: 16602110     Source Type: Journal    
DOI: 10.1159/000323392     Document Type: Article

References (39)

1. Swift PA, Markandu ND, Sagnella GA, et al: Modest salt reduction reduces blood pressure and urine protein excretion in black hypertensives: A randomized control trial. Hypertension 2005; 46: 308-312. (Pubitemid 41099162)
2. Weir MR, Fink JC: Salt intake and progression of chronic kidney disease: An overlooked modifiable exposure? A commentary. Am J Kidney Dis 2005; 45: 176-188. (Pubitemid 40038059)
3. Sacks FM, Svetkey LP, Vollmer WM, et al: Effects on blood pressure of reduced dietary sodium and the Dietary Approaches to Stop Hypertension (DASH) diet. DASH-Sodium Collaborative Research Group. N Engl J Med 2001; 344: 3-10. (Pubitemid 32064838)
4. Weir MR, Dengel DR, Behrens MT, Goldberg AP: Salt-induced increases in systolic blood pressure affect renal hemodynamics and proteinuria. Hypertension 1995; 25: 1339-1344.
5. Boegehold MA: Effect of dietary salt on arteriolar nitric oxide in striated muscle of normotensive rats. Am J Physiol 1993; 264:H1810-H1816. (Pubitemid 23205950)
6. Lenda DM, Sauls BA, Boegehold MA: Reactive oxygen species may contribute to reduced endothelium-dependent dilation in rats fed high salt. Am J Physiol Heart Circ Physiol 2000; 279:H7-H14. (Pubitemid 30616642)
7. Ying WZ, Sanders PW: Dietary salt modulates renal production of transforming growth factor-beta in rats. Am J Physiol 1998; 274:F635-F641.
8. Ying WZ, Sanders PW: Dietary salt increases endothelial nitric oxide synthase and TGFbeta1 in rat aortic endothelium. Am J Physiol 1999; 277:H1293-H1298. (Pubitemid 29522657)
9. Kitiyakara C, Chabrashvili T, Chen Y, et al: Salt intake, oxidative stress, and renal expression of NADPH oxidase and superoxide dismutase. J Am Soc Nephrol 2003; 14: 2775-2782. (Pubitemid 37305640)
10. Sanders PW: Salt intake, endothelial cell signaling, and progression of kidney disease. Hypertension 2004; 43: 142-146. (Pubitemid 38174163)
11. Sanders PW: Effect of salt intake on progression of chronic kidney disease. Curr Opin Nephrol Hypertens 2006; 15: 54-60.
12. Krikken JA, Lely AT, Bakker SJ, Navis G: The effect of a shift in sodium intake on renal hemodynamics is determined by body mass index in healthy young men. Kidney Int 2007; 71: 260-265. (Pubitemid 46160927)
13. Vogt L, Waanders F, Boomsma F, et al: Effects of dietary sodium and hydrochlorothiazide on the antiproteinuric efficacy of losartan. J Am Soc Nephrol 2008; 19: 999-1007.
14. Bigazzi R, Bianchi S, Baldari D, et al: Microalbuminuria in salt-sensitive patients. A marker for renal and cardiovascular risk factors. Hypertension 1994; 23: 195-199. (Pubitemid 24050280)
15. Esnault VL, Ekhlas A, Delcroix C, et al: Diuretic and enhanced sodium restriction results in improved antiproteinuric response to RAS blocking agents. J Am Soc Nephrol 2005; 16: 474-481. (Pubitemid 41725144)
16. Buter H, Hemmelder MH, Navis G, et al: The blunting of the antiproteinuric efficacy of ACE inhibition by high sodium intake can be restored by hydrochlorothiazide. Nephrol Dial Transplant 1998; 13: 1682-1685. (Pubitemid 28306794)
17. Houlihan CA, Allen TJ, Baxter AL, et al: A low sodium diet potentiates the effects of losartan in type 2 diabetes. Diabetes Care 2002; 25: 663-671. (Pubitemid 41071184)
18. National Kidney Foundation: K/DOQI clinical practice guidelines on hypertension and antihypertensive agents in chronic kidney disease. Am J Kidney Dis 2004; 43(Suppl 1):S1-S290.
19. Chobanaian AV, Bakris GL, Black HR, Cushman WC: The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, Treatment of High Blood Pressure: The JNC 7 report. JAMA 2003; 289: 2560.
20. Mancia G, De Backer G, Dominiczak A, et al: Guidelines for the Management of Arterial Hypertension. The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J Hypertens 2007; 25: 1105-1187. (Pubitemid 46924065)
21. WHO: Forum and Technical Meeting on Reducing Salt Intake in the Population. Paris, October 2006.
22. Levey AS, Bosch JP, Lewis JB, et al: A more accurate method to estimate glomerular filtration rate from serum creatinine: A new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med 1999; 130: 461-470. (Pubitemid 29135798)
23. K/DOQI clinical practice guidelines for chronic kidney disease: Evaluation, classification, and stratification. Am J Kidney Dis 2002; 39:S1-S266.
24. Klahr S, Levey AS, Beck GJ, et al: The effects of dietary protein restriction and blood pressure control on the progression of chronic renal disease. Modification of Diet in Renal Disease Study Group. N Engl J Med 1994; 330: 877-884. (Pubitemid 24094966)
25. Brenner BM, Cooper ME, de Zeeuw D, et al: Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy. N Engl J Med 2001; 345: 861-869.
26. Parving HH, Persson F, Lewis JB, et al: Aliskiren combined with losartan in type 2 diabetes and nephropathy. N Engl J Med 2008; 358: 2433-2446. (Pubitemid 351793017)
27. Wright JT Jr., Bakris G, Greene T, et al: Effect of blood pressure lowering and antihypertensive drug class on progression of hypertensive kidney disease: Results from the AASK trial. JAMA 2002; 288: 2421-2431. (Pubitemid 35340538)
28. Parving HH, Lehnert H, Brochner-Mortensen J, et al: The effect of irbesartan on the development of diabetic nephropathy in patients with type 2 diabetes. N Engl J Med 2001; 345: 870-878.
29. Maschio G, Alberti D, Janin G, et al: Effect of the angiotensin- converting-enzyme inhibitor benazepril on the progression of chronic renal insufficiency. The Angiotensin-Converting-Enzyme Inhibition in Progressive Renal Insufficiency Study Group. N Engl J Med 1996; 334: 939-945. (Pubitemid 26114159)
30. De Nicola L, Minutolo R, Chiodini P, et al: Global approach to cardiovascular risk in chronic kidney disease: Reality and opportunities for intervention. Kidney Int 2006; 69: 538-545. (Pubitemid 43164447)
31. Van Zuilen AD, Wetzels JF, Bots ML, Van Blankestijn PJ, MASTERPLAN Study Group: MASTERPLAN: Study of the role of nurse practitioners in a multifactorial intervention to reduce cardiovascular risk in chronic kidney disease patients. J Nephrol 2008; 21: 261-267.
32. Ruggenenti P, Perna A, Loriga G, et al: Bloodpressure control for renoprotection in patients with nondiabetic chronic renal disease (REIN-2): Multicentre, randomised controlled trial. Lancet 2005; 365: 939-946. (Pubitemid 41071427)
33. Tuomilehto J, Jousilahti P, Rastenyte D, et al: Urinary sodium excretion and cardiovascular mortality in Finland: A prospective study. Lancet 2001; 357: 848-851. (Pubitemid 32239370)
34. Intersalt: An international study of electrolyte excretion and blood pressure. Results for 24 hour urinary sodium and potassium excretion. Intersalt Cooperative Research Group. BMJ 1988; 297: 319-328.
35. Erdem Y, Arici M, Altun B, et al: The relationship between hypertension and salt intake in Turkish population: SALTURK study. Blood Press 2010; 19: 313-318.
36. Boudville N, Ward S, Benaroia M, House AA: Increased sodium intake correlates with greater use of antihypertensive agents by subjects with chronic kidney disease. Am J Hypertens 2004; 18: 1300-1305. (Pubitemid 41400198)
37. Bellizzi V, Di Iorio BR, De Nicola L, et al: Very low protein diet supplemented with ketoanalogs improves blood pressure control in chronic kidney disease. Kidney Int 2007; 71: 245-251. (Pubitemid 46160925)
38. Ikizler TA, Greene JH, Wingard RL, et al: Spontaneous dietary protein intake during progression of chronic renal failure. J Am Soc Nephrol 1995; 6: 1386-1391.
39. Bibbins-Domingo K, Chertow GM, Coxson PG, et al: Projected effect of dietary salt reductions on future cardiovascular disease. N Engl J Med 2010; 362: 590-599.